|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000099284 |
Summary for H2AFY2 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000099284 | Gene symbol | H2AFY2 |
| Gene name | macroH2A.2 histone | |
| HGNC | 14453 | |
| Entrez ID | 55506 | |
| Gene type | protein_coding | |
| Synonyms | MACROH2A2| | |
| UniProtAcc | Q9P0M6 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for H2AFY2 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| H2AFY2 | 1.73e+03 | -1.42e+00 | 3.74e-01 | -3.81e+00 | 1.38e-04 | 2.63e-03 | BRCA |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| H2AFY2 | 9.27e+02 | -1.02e+00 | 2.86e-01 | -3.58e+00 | 3.38e-04 | 9.80e-04 | KICH |
| H2AFY2 | 9.74e+02 | 1.49e+00 | 5.77e-01 | 2.58e+00 | 9.78e-03 | 2.45e-02 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| H2AFY2 | 1.00e+03 | 1.41e+00 | 3.47e-01 | 4.06e+00 | 4.86e-05 | 1.68e-04 | LIHC |
Top |
Sex-biased somatic mutation for H2AFY2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for H2AFY2 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg13626863 | chr10:70054156 | CGI:chr10:70052562-70053937 | promoter,gene body | 3.04e-01 | 4.70e-01 | -2.29e+00 | 2.23e-02 | 3.65e-02 | -1.66e-01 |
| DLBC | cg14165614 | chr10:70052345 | CGI:chr10:70052562-70053937 | promoter | 5.73e-01 | 6.76e-01 | 2.05e+00 | 4.05e-02 | 4.68e-02 | -1.02e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg13626863 | chr10:70054156 | CGI:chr10:70052562-70053937 | promoter,gene body | 2.99e-01 | 1.77e-01 | 5.45e+00 | 4.95e-08 | 2.74e-07 | 1.22e-01 |
| LUAD | cg19726179 | chr10:70053597 | CGI:chr10:70052562-70053937 | promoter,gene body | 1.24e-01 | 1.83e-02 | 3.89e+00 | 1.01e-04 | 2.83e-04 | 1.06e-01 |
| LUSC | cg18009000 | chr10:70052171 | CGI:chr10:70052562-70053937 | promoter | 5.36e-01 | 7.32e-01 | -3.41e+00 | 6.49e-04 | 1.96e-03 | -1.97e-01 |
| LUSC | cg20336571 | chr10:70052378 | CGI:chr10:70052562-70053937 | promoter | 4.22e-01 | 5.31e-01 | -2.79e+00 | 5.22e-03 | 8.43e-03 | -1.09e-01 |
| CHOL | cg20336571 | chr10:70052378 | CGI:chr10:70052562-70053937 | promoter | 5.09e-01 | 6.52e-01 | -1.99e+00 | 4.65e-02 | 4.65e-02 | -1.43e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg13626863 | chr10:70054156 | CGI:chr10:70052562-70053937 | promoter,gene body | 3.04e-01 | 1.98e-01 | 8.43e+00 | 3.40e-17 | 1.47e-16 | 1.06e-01 |
| KIRC | cg18009000 | chr10:70052171 | CGI:chr10:70052562-70053937 | promoter | 8.05e-01 | 6.79e-01 | 3.03e+00 | 2.48e-03 | 7.26e-03 | 1.26e-01 |
| LUAD | cg13626863 | chr10:70054156 | CGI:chr10:70052562-70053937 | promoter,gene body | 4.12e-01 | 2.83e-01 | 3.19e+00 | 1.41e-03 | 4.02e-03 | 1.29e-01 |
| HNSC | cg13626863 | chr10:70054156 | CGI:chr10:70052562-70053937 | promoter,gene body | 3.99e-01 | 2.62e-01 | 2.62e+00 | 8.69e-03 | 1.73e-02 | 1.37e-01 |
| COAD | cg20336571 | chr10:70052378 | CGI:chr10:70052562-70053937 | promoter | 4.78e-01 | 3.47e-01 | 2.76e+00 | 5.82e-03 | 1.06e-02 | 1.31e-01 |
| LIHC | cg20336571 | chr10:70052378 | CGI:chr10:70052562-70053937 | promoter | 5.61e-01 | 6.97e-01 | -2.58e+00 | 9.75e-03 | 1.36e-02 | -1.36e-01 |
Top |
Exon skipping events with PSI in TCGA for H2AFY2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for H2AFY2 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for H2AFY2 |
| TFs related to H2AFY2. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| H2AFY2 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for H2AFY2 |
| RBPs related to ES in H2AFY2. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| H2AFY2 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4546981 | chr10:65755859:T:A | - | 0.808025515718037 | 0.0432741083508244 | GBM | Female-baised eQTL |
| rs10824533 | chr10:77356791:C:T | - | 0.034585514699726 | 0.0480173992027885 | THCA | Female-baised eQTL |
| rs67734810 | chr10:77360098:A:C | - | 0.034585514699726 | 0.0480173992027885 | THCA | Female-baised eQTL |
| rs1439785 | chr10:77371524:T:G | - | 0.034494034915748 | 0.0483665946225256 | THCA | Female-baised eQTL |
| rs16928098 | chr10:70907019:C:T | - | 0.160089963428573 | 0.00266638846872082 | SARC | Female-baised eQTL |
| rs2758984 | chr10:76304028:T:C | - | -0.121414273275599 | 0.00339165875579165 | LIHC | Female-baised eQTL |
| rs2579789 | chr10:76300621:G:C | - | -0.107097636834599 | 0.0088591665424877 | LIHC | Female-baised eQTL |
| rs2579786 | chr10:76304465:G:A | - | -0.114923847218539 | 0.00923977228794534 | LIHC | Female-baised eQTL |
| rs989301 | chr10:76308982:T:G | - | -0.114434134192525 | 0.0176410052015301 | LIHC | Female-baised eQTL |
| rs2758965 | chr10:76319775:A:G | - | -0.114434134192525 | 0.0176410052015301 | LIHC | Female-baised eQTL |
| rs2573555 | chr10:76302813:A:G | - | -0.110617472982833 | 0.0196714355003547 | LIHC | Female-baised eQTL |
| rs2579777 | chr10:76329906:A:C | - | -0.110366084466237 | 0.0219201146248549 | LIHC | Female-baised eQTL |
| rs2758983 | chr10:76305877:A:T | - | -0.111265936496258 | 0.0259222696475705 | LIHC | Female-baised eQTL |
| rs1923614 | chr10:76305017:A:G | - | -0.109981365551738 | 0.0307577806692636 | LIHC | Female-baised eQTL |
| rs2395373 | chr10:76339557:C:T | - | -0.105263039713424 | 0.031534710235292 | LIHC | Female-baised eQTL |
| rs2395374 | chr10:76344169:A:C | - | -0.105263039713424 | 0.031534710235292 | LIHC | Female-baised eQTL |
| rs2758977 | chr10:76310278:T:A | - | -0.109774015900666 | 0.0327009671426867 | LIHC | Female-baised eQTL |
| rs2758970 | chr10:76317580:G:T | - | -0.109774015900666 | 0.0327009671426867 | LIHC | Female-baised eQTL |
| rs2104206 | chr10:76315669:G:A | - | -0.107163495321684 | 0.033916121560823 | LIHC | Female-baised eQTL |
| rs2758978 | chr10:76308484:G:A | - | -0.107708935759932 | 0.0386010047938493 | LIHC | Female-baised eQTL |
| rs2758964 | chr10:76319861:A:G | - | -0.107708935759932 | 0.0386010047938493 | LIHC | Female-baised eQTL |
| rs2758961 | chr10:76320554:G:A | - | -0.107708935759932 | 0.0386010047938493 | LIHC | Female-baised eQTL |
| rs967948 | chr10:76318401:T:C | - | -0.105510063164742 | 0.0388293436987425 | LIHC | Female-baised eQTL |
| rs4745813 | chr10:76337014:A:T | - | -0.101928215439737 | 0.0406189398756895 | LIHC | Female-baised eQTL |
| rs2758975 | chr10:76311796:C:T | - | -0.104620688710533 | 0.0440479367778321 | LIHC | Female-baised eQTL |
| rs72809242 | chr10:70383461:C:G | - | 0.211166618890652 | 1.86473514281139e-05 | STAD | Female-baised eQTL |
| rs1904594 | chr10:70384502:A:C | - | 0.211166618890652 | 1.86473514281139e-05 | STAD | Female-baised eQTL |
| rs9415644 | chr10:62115403:A:G | - | 0.123906647453284 | 0.000298863704904932 | STAD | Female-baised eQTL |
| rs9415643 | chr10:62111663:C:T | - | 0.125250628196738 | 0.000307500019563843 | STAD | Female-baised eQTL |
| rs9414765 | chr10:62119962:A:G | - | 0.128621065367464 | 0.00056161826524704 | STAD | Female-baised eQTL |
| rs9415647 | chr10:62122435:C:T | - | 0.128636049035353 | 0.000571657670157354 | STAD | Female-baised eQTL |
| rs9415649 | chr10:62126011:T:C | - | 0.128636049035353 | 0.000571657670157354 | STAD | Female-baised eQTL |
| rs9414766 | chr10:62131356:G:A | - | 0.128412128479757 | 0.000611310451596536 | STAD | Female-baised eQTL |
| rs7078374 | chr10:62071879:G:A | - | -0.115108143804195 | 0.00081300652437722 | STAD | Female-baised eQTL |
| rs9415637 | chr10:62080506:T:G | - | 0.109770890306151 | 0.00136625250745525 | STAD | Female-baised eQTL |
| rs9414759 | chr10:62080910:C:T | - | 0.109770890306151 | 0.00136625250745525 | STAD | Female-baised eQTL |
| rs3125731 | chr10:62187235:T:C | - | -0.135122647597017 | 0.00272643938998828 | STAD | Female-baised eQTL |
| rs3125732 | chr10:62187637:C:T | - | -0.135122647597017 | 0.00272643938998828 | STAD | Female-baised eQTL |
| rs4979769 | chr10:62161071:T:C | - | -0.134816187594568 | 0.0029232704508688 | STAD | Female-baised eQTL |
| rs17363658 | chr10:75946649:A:G | - | 0.100689566955992 | 0.0119220147922449 | STAD | Female-baised eQTL |
| rs10999304 | chr10:70376244:C:T | - | 0.12103587062179 | 0.0151197741528569 | STAD | Female-baised eQTL |
| rs72809238 | chr10:70369561:G:A | - | 0.124449784506822 | 0.0180130591718491 | STAD | Female-baised eQTL |
| rs10997701 | chr10:67540736:T:C | - | 0.0787773299910437 | 0.00527822404572461 | KIRC | Female-baised eQTL |
| rs7101097 | chr10:70362053:T:C | - | -0.128922926751865 | 0.00576162587976435 | KIRC | Female-baised eQTL |
| rs7071129 | chr10:70362331:T:C | - | -0.131932222846407 | 0.006036931913491 | KIRC | Female-baised eQTL |
| rs12252661 | chr10:67592708:A:T | - | 0.0673482550920751 | 0.00928304066412387 | KIRC | Female-baised eQTL |
| rs7097343 | chr10:73602031:C:A | - | 0.0716317156970948 | 0.00940818389961373 | KIRC | Female-baised eQTL |
| rs2394407 | chr10:67593586:G:C | - | 0.0660816958163726 | 0.0129911918386628 | KIRC | Female-baised eQTL |
| rs12256629 | chr10:67594533:A:G | - | 0.0660816958163726 | 0.0129911918386628 | KIRC | Female-baised eQTL |
| rs10823074 | chr10:67596063:A:G | - | 0.0660816958163726 | 0.0129911918386628 | KIRC | Female-baised eQTL |
| rs10823070 | chr10:67580358:A:C | - | 0.0639840919678827 | 0.0215131027015566 | KIRC | Female-baised eQTL |
| rs368656203 | chr10:67580490:A:G | - | 0.0639840919678827 | 0.0215131027015566 | KIRC | Female-baised eQTL |
| rs117297607 | chr10:67581197:C:G | - | 0.0639840919678827 | 0.0215131027015566 | KIRC | Female-baised eQTL |
| rs2088716 | chr10:67584704:A:G | - | 0.063702816354205 | 0.0227056607607645 | KIRC | Female-baised eQTL |
| rs7920668 | chr10:67585818:A:T | - | 0.0636495859759464 | 0.0232786076721212 | KIRC | Female-baised eQTL |
| rs12263974 | chr10:65594458:T:A | - | 0.101621792424568 | 0.0329236586441337 | KIRC | Female-baised eQTL |
| rs10997730 | chr10:67574066:A:G | - | 0.0648788534037209 | 0.0332550641861015 | KIRC | Female-baised eQTL |
| rs10509290 | chr10:67542727:G:T | - | 0.0689877956856952 | 0.0474264060960951 | KIRC | Female-baised eQTL |
| rs10128376 | chr10:67531389:A:G | - | 0.0689653886712915 | 0.0482032859667589 | KIRC | Female-baised eQTL |
| rs6480270 | chr10:67534174:T:C | - | 0.0689653886712915 | 0.0482032859667589 | KIRC | Female-baised eQTL |
| rs10996565 | chr10:65645600:C:T | - | 0.0952758110195467 | 0.0494338167503588 | KIRC | Female-baised eQTL |
| rs10823021 | chr10:67294976:G:C | - | 0.203348452429115 | 0.000603222144205406 | BLCA | Female-baised eQTL |
| rs2616679 | chr10:67310892:A:G | - | -0.14393851793533 | 0.0273674062017888 | BLCA | Female-baised eQTL |
| rs2616681 | chr10:67311624:C:T | - | -0.14393851793533 | 0.0273674062017888 | BLCA | Female-baised eQTL |
| rs58957937 | chr10:70706399:G:A | - | 0.127665678581055 | 0.0461643703926985 | BLCA | Female-baised eQTL |
| rs58433219 | chr10:70706319:C:T | - | 0.126869001142999 | 0.0480951464200388 | BLCA | Female-baised eQTL |
| rs72814564 | chr10:70710832:C:T | - | 0.126869001142999 | 0.0480951464200388 | BLCA | Female-baised eQTL |
| rs59538488 | chr10:70705530:G:T | - | 0.126781033393185 | 0.0492967222382262 | BLCA | Female-baised eQTL |
| rs7083975 | chr10:65325723:T:C | - | 0.0600792877675118 | 0.0293606359739391 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1259504 | chr10:75233257:C:T | - | 0.0738491077731453 | 0.0102514058927784 | KIRC | Male-baised eQTL |
| rs10824290 | chr10:75204210:G:A | - | 0.0613599482933355 | 0.0146519208982065 | KIRC | Male-baised eQTL |
| rs2657289 | chr10:75206705:C:T | - | 0.0602915203723022 | 0.0185487314393116 | KIRC | Male-baised eQTL |
| rs11001287 | chr10:75075572:C:A | - | 0.067410290504322 | 0.0214171345838889 | KIRC | Male-baised eQTL |
| rs1259500 | chr10:75230355:A:G | - | 0.0580632042361909 | 0.022189991545157 | KIRC | Male-baised eQTL |
| rs11001286 | chr10:75075224:C:T | - | 0.0654191334423508 | 0.0240037458434636 | KIRC | Male-baised eQTL |
| rs1259503 | chr10:75232686:C:G | - | 0.0575170270696232 | 0.025313517036235 | KIRC | Male-baised eQTL |
| rs1149715 | chr10:75289591:C:T | - | -0.0621949303176089 | 0.028220144924625 | KIRC | Male-baised eQTL |
| rs1149716 | chr10:75290629:T:C | - | -0.0612227207963229 | 0.0332539281849621 | KIRC | Male-baised eQTL |
| rs1777414 | chr10:75274305:T:C | - | -0.0563422468379707 | 0.0347463424513188 | KIRC | Male-baised eQTL |
| rs191798086 | chr10:67692102:C:G | - | 0.055849175351988 | 0.0456063928510326 | BLCA | Male-baised eQTL |
| rs17455801 | chr10:78550302:T:C | - | 0.0858347732723915 | 0.0120568861260884 | LUAD | Male-baised eQTL |
| rs16927349 | chr10:70137439:C:T | - | 0.100675829198414 | 0.0138012184797873 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000099284 |
| CpG Site: cg20336571 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.382675466909801 | |
 | Gene ID: ENSG00000099284 |
| CpG Site: cg20336571 | |
| Position to Gene: promoter | |
| Male Effect: -0.438789718382783 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg20336571 | chr10:70052378 | promoter | -0.438789718382783 | 3.102465939757e-06 | -0.36790532287263844 | 1.8622032237102885e-08 | STAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg20336571 | chr10:70052378 | promoter | -0.382675466909801 | 2.69810749134777e-15 | -0.51616875494396 | 9.139719270845089e-19 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of H2AFY2 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
